Kanoria Chemicals Board Approves Share Offer Document
Kanoria Chemicals & Industries' Board has approved the offer document for its redeemable preference shares. This action follows shareholder approval to increase the company's capital, moving the company closer to securing funds for expansion and operations. Details on the specific terms of the share issuance are still pending.
Board Approves Share Offer Document
Kanoria Chemicals & Industries Limited's Board of Directors met on April 13, 2026, approving the formal offer document for its redeemable preference shares.
The approval covers the issuance of Non-Convertible, Non-Cumulative, Non-Participating, Redeemable Preference Shares (NCRPS).
The brief meeting, which lasted about 20 minutes, marks a step forward from the company's earlier Extra-Ordinary General Meeting (EOGM) held on April 1, 2026.
Why This Capital Raise Matters
Preference shares provide a way to raise capital without significantly reducing the ownership stake of existing shareholders.
This move is important as the company seeks to improve its financial standing for upcoming growth and operational requirements.
Company Background and Previous Approvals
Kanoria Chemicals & Industries (KCI) operates in the chemical intermediates and specialty chemicals sector, with diversified interests in automotive electronics, renewable energy, and textiles.
At a shareholder meeting on April 1, 2026, members approved increasing the company's authorized share capital from ₹50 crore to ₹100 crore.
Shareholders also sanctioned the issuance of ₹50 crore in redeemable preference shares to M/s. R. V. Investment and Dealers Limited.
The raised funds are intended for capital expenditure, working capital, and general corporate purposes.
Next Steps in the Capital Raise
Shareholders can expect the formal offer document, which will detail the terms of the preference share issuance.
This approval allows the company to move forward with the planned capital raise, which could improve its financial flexibility.
The process now progresses from shareholder approval to the formal offer document stage.
Financial and Operational Risks
The company has faced financial challenges, including a consolidated net loss of INR 1,081 million in FY25.
In March 2025, CARE Ratings downgraded its bank facilities due to group exposure and slowing financial performance.
Its results for Q1 FY25 showed significant drops in profits (profit before and after tax) and a worsened interest coverage ratio.
Additionally, in September 2024, the Ankleshwar plant received a closure order from the GPCB over alleged pollution, though this was later revoked.
Industry Context
KCI operates in the Indian chemical industry alongside major companies such as Pidilite Industries, SRF Ltd, and Aarti Industries.
These competitors are known for their diversified chemical businesses and specialty chemical manufacturing.
While specific comparisons of funding strategies using preference shares are not readily available, KCI's action aims to bolster its balance sheet within this competitive sector.
Key Figures and Dates
- Authorized share capital was proposed to increase from ₹50.00 crore to ₹100.00 crore following the April 2026 EGM.
- A preference share issuance of up to ₹50.00 crore is planned.
Key Details for Investors to Watch
Specific terms of the preference share issuance, including dividend rate, tenure, and pricing.
Further regulatory filings and announcements about the completion of the share offering.
How the company will use the raised capital and its effect on financial performance.
Any updates on operational improvements or market conditions impacting the company.
